Open House Drug Discount Agreements Carbamazepine Atc N03Af01

Deadline: 05 Dec 2026

Germany

Ref. No.: 11643701

EMD:Ref Document

Bid Value: Ref Document

184 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Flupentixol Obg Atc N05Af01 For The Period 01 02 2025 31 01 2027

Deadline: 04 Dec 2026

Germany

Ref. No.: 11637168

EMD:Ref Document

Bid Value: Ref Document

183 Days Left

Open House Drug Discount Agreements Trientin Atc A16Ax12

Deadline: 05 Dec 2026

Germany

Ref. No.: 11636038

EMD:Ref Document

Bid Value: Ref Document

184 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Lipegfilgrastim Obo Atc L03Aa14 For The Period 01 02 2025 31 01 2027

Deadline: 04 Dec 2026

Germany

Ref. No.: 11635849

EMD:Ref Document

Bid Value: Ref Document

183 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Peg Epoetin Beta Obo Atc B03Xa03 For The Period 01 02 2025 31 01 2027

Deadline: 04 Dec 2026

Germany

Ref. No.: 11631033

EMD:Ref Document

Bid Value: Ref Document

183 Days Left

Open Framework Agreement On Drug Discounts Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V With The Option To Join At Any Time So Called Approval Model 2025 02 Of The German Pension Insurance Knappschaft Bahn See

Deadline: 05 Dec 2026

Germany

Ref. No.: 11582456

EMD:Ref Document

Bid Value: Ref Document

184 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11494431

EMD:Ref Document

Bid Value: Ref Document

210 Days Left

Pharmaceutical Discount Agreements From February 1 2025 For Various Active Ingredients Within The Framework Of An Open House Procedure

Deadline: 02 Dec 2026

Germany

Ref. No.: 11481969

EMD:Ref Document

Bid Value: Ref Document

181 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11447759

EMD:Ref Document

Bid Value: Ref Document

210 Days Left

Medicines Containing The Active Ingredient Secukinumab Atc L04Ac10

Deadline: 30 Nov 2026

Germany

Ref. No.: 11381212

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Medicines Containing The Active Ingredient Pegfilgrastim Atc L03Aa13

Deadline: 30 Nov 2026

Germany

Ref. No.: 11379830

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Medicines Containing The Active Ingredient Leuprorelin Atc L02Ae02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11373594

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Medicines Containing The Active Ingredient Mesalazine Atc A07Ec02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11362644

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Medicines Containing The Active Ingredient Pyridostigmine Atc N07Aa02

Deadline: 30 Nov 2026

Germany

Ref. No.: 11352492

EMD:Ref Document

Bid Value: Ref Document

179 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 11341666

EMD:Ref Document

Bid Value: Ref Document

210 Days Left

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!